PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+8.55%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$5.41B
AUM Growth
+$174M
(+3.3%)
Cap. Flow
-$97.1M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
21.52%
Holding
287
New
40
Increased
91
Reduced
93
Closed
30
Top Buys
| 1 |
Merck
MRK
|
$53.9M |
| 2 |
Canadian Natural Resources
CNQ
|
$52.7M |
| 3 |
Abbott
ABT
|
$36.8M |
| 4 |
Amgen
AMGN
|
$34.6M |
| 5 |
Edwards Lifesciences
EW
|
$29.3M |
Top Sells
| 1 |
Pfizer
PFE
|
$63.6M |
| 2 |
N
Netsuite Inc
N
|
$43.9M |
| 3 |
AGN
Allergan plc
AGN
|
$39.6M |
| 4 |
eBay
EBAY
|
$34.2M |
| 5 |
BCR
CR Bard Inc.
BCR
|
$33.1M |
Sector Composition
| 1 | Technology | 23.12% |
| 2 | Healthcare | 22.69% |
| 3 | Financials | 21.9% |
| 4 | Communication Services | 10.68% |
| 5 | Consumer Discretionary | 5.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
National Health Investors
NHI
$3.67B
| $1.96M | 0.03% |
25,000
| – | – |
|
202
Supernus Pharmaceuticals
SUPN
$2.55B
| $1.92M | 0.03% |
77,500
-33,025
| -30% | -$817K |
|
|
MTLS
203
Materialise
MTLS
$294M
| $1.9M | 0.03% |
246,790
+79,799
| +48% | +$614K |
|
204
Sabra Healthcare REIT
SBRA
$4.58B
| $1.89M | 0.03% |
75,000
| – | – |
|
|
MON
205
DELISTED
Monsanto Co
MON
| $1.82M | 0.03% |
17,797
-18,557
| -51% | -$1.9M |
|
206
Omega Healthcare
OHI
$12.6B
| $1.77M | 0.03% |
50,000
| – | – |
|
|
NSTG
207
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.62M | 0.03% |
81,000
-19,000
| -19% | -$380K |
|
208
Vertex Pharmaceuticals
VRTX
$102B
| $1.61M | 0.03% |
18,500
-11,181
| -38% | -$975K |
|
|
WBA
209
DELISTED
Walgreens Boots Alliance
WBA
| $1.61M | 0.03% |
20,000
-300,000
| -94% | -$24.2M |
|
|
NGD
210
New Gold Inc
NGD
$4.86B
| $1.6M | 0.03% |
362,611
-400,337
| -52% | -$1.77M |
|
211
Healthcare Services Group
HCSG
$1.14B
| $1.52M | 0.03% |
38,372
| – | – |
|
212
HCA Healthcare
HCA
$96.3B
| $1.51M | 0.03% |
20,000
-301,027
| -94% | -$22.8M |
|
213
Pacira BioSciences
PCRX
$1.2B
| $1.17M | 0.02% |
34,100
-14,096
| -29% | -$482K |
|
214
Tesla
TSLA
$1.09T
| $1.16M | 0.02% |
85,200
-51,000
| -37% | -$693K |
|
215
HDFC Bank
HDB
$181B
| $1.13M | 0.02% |
31,534
| – | – |
|
216
Brookdale Senior Living
BKD
$1.82B
| $1.05M | 0.02% |
60,000
+32,981
| +122% | +$576K |
|
217
Jazz Pharmaceuticals
JAZZ
$7.77B
| $1.03M | 0.02% |
8,500
-172,385
| -95% | -$20.9M |
|
|
AUY
218
DELISTED
Yamana Gold, Inc.
AUY
| $912K | 0.02% |
205,575
-491,425
| -71% | -$2.18M |
|
|
VIVO
219
DELISTED
Meridian Bioscience Inc
VIVO
| $860K | 0.01% |
44,600
+1,800
| +4% | +$34.7K |
|
220
Rocket Pharmaceuticals
RCKT
$349M
| $711K | 0.01% |
18,750
+1,824
| +11% | +$69.2K |
|
|
AKAO
221
DELISTED
Achaogen, Inc.
AKAO
| $695K | 0.01% |
145,000
+45,000
| +45% | +$216K |
|
|
TRIL
222
DELISTED
Trillium Therapeutics Inc.
TRIL
| $488K | 0.01% |
+33,000
| New | +$488K |
|
223
Citizens Financial Group
CFG
$22.7B
| $438K | 0.01% |
17,707
-7,087
| -29% | -$175K |
|
|
OPB
224
DELISTED
Opus Bank Common Stock
OPB
| $427K | 0.01% |
12,059
+2,256
| +23% | +$79.9K |
|
|
ADAP
225
Adaptimmune Therapeutics
ADAP
$13.5M
| $423K | 0.01% |
60,000
+10,000
| +20% | +$70.5K |
|